| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Other Original Articles |
National Center for Infertility Research and Reproductive Endocrine Unit, Massachusetts General Hospital, Boston, Massachusetts 02114; Department of Pathology and Laboratory Medicine, Women and Infants Hospital (G.L.M.), Providence, Rhode Island 02903; and Department of Obstetrics and Gynecology, Brigham and Womens Hospital (J.F.), Boston, Massachusetts 02115
Address all correspondence and requests for reprints to: Dr. Alan Schneyer, Reproductive Endocrine Unit, BHX-5, Massachusetts General Hospital, Boston, Massachusetts 02114. E-mail: schneyer.alan{at}mgh.harvard.edu
Abstract
To further explore the developmental dynamics and possible roles of
inhibin, activin, and follistatin in the development of human antral
follicles as well as the relationship between mRNA and protein levels
of these hormones within follicles, quantitative competitive RT-PCR
assays were established to determine mRNA levels for the
inhibin/activin subunits and both follistatin splice variants.
Granulosa cell RNA was obtained by transvaginally aspirating follicles
(623 mm) from carefully characterized normal women at different times
of the follicular phase.
- and ßA-subunit mRNA levels
increased significantly with follicle diameter (r = 0.56;
P < 0.01 and r = 0.45; P
< 0.05, respectively) and follicle maturity (r = 0.65;
P < 0.001 and r = 0.58; P
< 0.01, respectively), but ßB mRNA levels, which were at
least 10-fold lower than levels of the other subunits, showed no
relationship to size or maturity. Both follistatin 315 and 288
transcripts were detected in granulosa cells, but neither follistatin
transcript varied significantly across the range of follicle sizes
analyzed. In addition, granulosa cells contained three follistatin 315
mRNA transcripts for each follistatin 288 transcript, and the
follistatin 315/288 ratio did not vary with follicle size.
-Subunit
mRNA levels were positively associated with dimeric inhibin A protein
in human follicular fluid from the same follicle aspirates (r =
0.71; P < 0.001). Similarly,
ßA-subunit mRNA was associated with inhibin A (r =
0.59; P < 0.01), and ßB mRNA was
associated with inhibin B (r = 0.67; P <
0.005) in these samples. Thus, the increase in inhibin subunit
transcription and protein synthesis with follicle size suggests that
inhibin biosynthesis might be important for continued development of
the dominant follicle.
To explore this hypothesis further, we compared mRNA levels for each of
these transcripts in follicles obtained from six polycystic ovary
syndrome patients (eight follicles) and compared the results to those
from a group (n = 5) of normal follicles matched for mean
diameter. Comparisons were also performed for a subset of polycystic
ovary syndrome follicles (n = 5) matched for diameter and size
range with the normal group.
-Subunit mRNA levels were 16-fold lower
in both polycystic ovary syndrome follicle groups relative to
size-matched normal follicles (P < 0.02), whereas
ßA-subunit mRNA was significantly lower only when all
polycystic ovary syndrome follicles were compared.
ßB-Subunit and follistatin mRNA levels and the
follistatin 315/288 ratio were not statistically different for any
group. These results suggest that insufficient production of inhibin
and possibly ßA-subunits, but not follistatin, is
associated with follicular arrest in polycystic ovary syndrome
follicles.
This article has been cited by other articles:
![]() |
F.-T. Shi, A. P. Cheung, and P. C. K. Leung Growth Differentiation Factor 9 Enhances Activin A-Induced Inhibin B Production in Human Granulosa Cells Endocrinology, August 1, 2009; 150(8): 3540 - 3546. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-Y. Lin, R. G. Craythorn, A. E. O'Connor, M. M. Matzuk, J. E. Girling, J. R. Morrison, and D. M. de Kretser Female Infertility and Disrupted Angiogenesis Are Actions of Specific Follistatin Isoforms Mol. Endocrinol., February 1, 2008; 22(2): 415 - 429. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. G. Farnworth, P. G. Stanton, Y. Wang, R. Escalona, J. K. Findlay, and G. T. Ooi Inhibins Differentially Antagonize Activin and Bone Morphogenetic Protein Action in a Mouse Adrenocortical Cell Line Endocrinology, July 1, 2006; 147(7): 3462 - 3471. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Glister, N. P Groome, and P. G Knight Bovine follicle development is associated with divergent changes in activin-A, inhibin-A and follistatin and the relative abundance of different follistatin isoforms in follicular fluid J. Endocrinol., February 1, 2006; 188(2): 215 - 225. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. K. Welt, A. E. Taylor, J. Fox, G. M. Messerlian, J. M. Adams, and A. L. Schneyer Follicular Arrest in Polycystic Ovary Syndrome Is Associated with Deficient Inhibin A and B Biosynthesis J. Clin. Endocrinol. Metab., October 1, 2005; 90(10): 5582 - 5587. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.L. Juengel and K.P. McNatty The role of proteins of the transforming growth factor-{beta} superfamily in the intraovarian regulation of follicular development Hum. Reprod. Update, March 1, 2005; 11(2): 144 - 161. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Welt, Y. Sidis, H. Keutmann, and A. Schneyer Activins, Inhibins, and Follistatins: From Endocrinology to Signaling. A Paradigm for the New Millennium Experimental Biology and Medicine, October 1, 2002; 227(9): 724 - 752. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Pangas, A. W. Rademaker, D. A. Fishman, and T. K. Woodruff Localization of the Activin Signal Transduction Components in Normal Human Ovarian Follicles: Implications for Autocrine and Paracrine Signaling in the Ovary J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2644 - 2657. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Jaatinen, J. Bondestam, T. Raivio, K. Hilden, L. Dunkel, N. Groome, and O. Ritvos Activation of the Bone Morphogenetic Protein Signaling Pathway Induces Inhibin {beta}B-Subunit mRNA and Secreted Inhibin B Levels in Cultured Human Granulosa-Luteal Cells J. Clin. Endocrinol. Metab., March 1, 2002; 87(3): 1254 - 1261. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |